Exact compound and country check

Melanotan I in Malaysia

Melanotan I is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia.

Evidence lane
US research-market identity
Destination
Malaysia
Source records
3
Reviewed
21 July 2026
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

What does a search for Melanotan I in Malaysia need to establish?

Melanotan I is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia. Match the exact category, legal seller identity, and claimed route against the official records on this page.

02

Which official records should be checked for Melanotan I in Malaysia?

Resolve the exact identity of Melanotan I through Read the current SCENESSE label from National Library of Medicine, DailyMed. Then search QUEST3+ Product Search from National Pharmaceutical Regulatory Agency for the destination product record and Product registration FAQ from National Pharmaceutical Regulatory Agency for the seller, establishment, or supply route in Malaysia. A match in one record does not replace the other two checks.

03

Does an online listing prove Melanotan I is authorized or available in Malaysia?

No. A page using the name Melanotan I, local currency, a domestic delivery claim, or a familiar package image is only a lead. This record resolves seller-labelled Melanotan I research vials. Afamelanotide is the active ingredient in the separately regulated SCENESSE 16 mg implant, but a research vial does not inherit that medicine's product identity, indication, presentation, authorization, evidence, or supply chain. Every destination still requires exact product and seller records. For Malaysia, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Continue the exact comparison

Related country and compound records.

Compare another tracked name in Malaysia, or keep Melanotan I fixed and change the destination within Asia-Pacific. The identity, product, and seller checks remain separate.

Continue the exact comparison

Melanotan I in Asia-Pacific

Melanotan I across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Melanotan I is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia. Match the exact category, legal seller identity, and claimed route against the official records on this page.

Primary identity source: Read the current SCENESSE label / National Library of Medicine, DailyMed
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

Read the current SCENESSE label

Read the current SCENESSE label is maintained by National Library of Medicine, DailyMed. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Read the current SCENESSE label

QUEST3+ Product Search

QUEST3+ Product Search is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open QUEST3+ Product Search

Product registration FAQ

Product registration FAQ is maintained by National Pharmaceutical Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Product registration FAQ
Malaysia / Country guide

Malaysia market context.

Malaysia's NPRA distinguishes registered products from manufacturer, importer, and wholesaler licences. A MAL-looking number, hologram image, marketplace badge, research statement, or laboratory document should be matched to the current official product record and responsible entity.

  • NPRA defines a registered drug as one approved by the Drug Control Authority for sale or use in Malaysia and assigns it a registration number beginning with MAL.
  • NPRA says a product is considered registered when it appears in QUEST3+ with an active status, which can change with regulatory updates.
  • Manufacturers, importers, and wholesalers require separate licences for the relevant activities involving registered products, so a product result alone does not verify the seller route.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Search QUEST3+ by exact details

Use the NPRA product search with the MAL number, product name, holder, manufacturer, importer, or active ingredient, and confirm that the returned status is active at the time of the search.

02

Match the label and holder

Compare the registration number, product category, holder, manufacturer, dosage form, and pack to the offer. A copied MAL number or similar product name is not a complete match.

03

Separate supplier licensing

Confirm the relevant manufacturer, import, or wholesale authority independently because NPRA treats product registration and the licences for supply activities as different controls.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

Audit and handoff

Keep the exact record attached.